Tempus AI (NASDAQ:TEM) EVP Andrew Polovin Sells 5,205 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Andrew Polovin sold 5,205 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total transaction of $341,135.70. Following the completion of the sale, the executive vice president owned 126,851 shares of the company’s stock, valued at approximately $8,313,814.54. The trade was a 3.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Andrew Polovin also recently made the following trade(s):

• On Wednesday, November 19th, Andrew Polovin sold 6,387 shares of Tempus AI stock. The stock was sold at an average price of $68.06, for a total transaction of $434,699.22.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $67.91 on Friday. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $104.32. The business has a fifty day simple moving average of $83.96 and a 200 day simple moving average of $71.87. The firm has a market cap of $12.08 billion, a price-to-earnings ratio of -57.07 and a beta of 4.86.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The firm had revenue of $334.21 million for the quarter, compared to the consensus estimate of $328.89 million. During the same quarter in the previous year, the company posted ($0.46) earnings per share. The business’s quarterly revenue was up 84.7% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Tempus AI

A number of hedge funds have recently made changes to their positions in the business. Bank of New York Mellon Corp lifted its holdings in shares of Tempus AI by 27.5% during the 1st quarter. Bank of New York Mellon Corp now owns 60,965 shares of the company’s stock worth $2,941,000 after acquiring an additional 13,142 shares during the period. Envestnet Asset Management Inc. increased its stake in Tempus AI by 37.0% in the first quarter. Envestnet Asset Management Inc. now owns 60,447 shares of the company’s stock valued at $2,916,000 after acquiring an additional 16,328 shares during the period. Signaturefd LLC acquired a new position in Tempus AI in the first quarter worth about $48,000. Victory Capital Management Inc. lifted its stake in Tempus AI by 45.3% during the first quarter. Victory Capital Management Inc. now owns 9,305 shares of the company’s stock worth $449,000 after purchasing an additional 2,901 shares during the period. Finally, Allianz Asset Management GmbH acquired a new position in shares of Tempus AI in the 1st quarter worth approximately $328,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Morgan Stanley raised their price objective on shares of Tempus AI from $68.00 to $80.00 and gave the company an “overweight” rating in a research report on Tuesday, November 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. Guggenheim boosted their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 26th. Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Finally, Needham & Company LLC lifted their target price on shares of Tempus AI from $70.00 to $100.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Tempus AI has a consensus rating of “Hold” and an average price target of $80.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.